Summary of laboratory pathological findings and clinical information in patients with extra-nodal non-cutaneous TCL.

Table 1: Summary of laboratory pathological findings and clinical information in patients with extra-nodal non-cutaneous TCL.

#	Age and Gender	Tumor site Specimen type	Pathological diagnosis	CBC findings	Staging evaluation	Treatment received for TCL	Follow-up (1-10 years)
1	96, female	Breast Excision	Peripheral TCL, NOS	Normal	Imaging	Lumpectomy	Alive
2	77, female	Breast Biopsy	Peripheral TCL, NOS	Normal	Imaging	Observation	Alive
3	43, female	Uterus Excision	Peripheral TCL, NOS	Anemia Thrombocytosis	Imaging	Hysterectomy	In remission
4	59, male	Stomach Biopsy	Peripheral TCL, NOS	Anemia	Imaging + bone marrow biopsy	Chemotherapy (CHOP)	Deceased
5	43, female	Kidney Excision	Peripheral TCL, NOS	Anemia	Imaging	Partial nephrectomy	Alive
6	52, male	Liver Biopsy	Peripheral TCL, NOS	Anemia Thrombocytopenia Lymphopenia	Imaging + bone marrow biopsy	Chemotherapy (CHOP)	Alive
7	33, male	Nasopharyngeal Biopsy	Extra-nodal T/NK cell lymphoma	Anemia	Imaging + bone marrow biopsy	Radiation + Chemotherapy	Deceased
8	39, male	Parotid gland Excision	ALCL, ALK- type	Anemia	Imaging + bone marrow biopsy	Parotidectomy	Alive
9	80, male	Small bowel Biopsy	Enteropathy associated T cell lymphoma	Anemia Lymphopenia	Imaging	Chemotherapy (CHOP)	In remission